TERESA SHERMAN-GACH: Open Payments
NPI 1144245218 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 33 payments from 15 companies in 2025. Trend: 2023 $672 · 2024 $823 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $104 |
| ABBVIE INC. | 5 | $83 |
| Exact Sciences Corporation | 4 | $74 |
| Amgen Inc. | 4 | $72 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Lilly USA, LLC | 3 | $45 |
| PFIZER INC. | 1 | $29 |
| Radius Health, Inc. | 1 | $27 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: The Cologuard Plus Collection Kit, OTEZLA, XIFAXAN, VRAYLAR, MOUNJARO, Rybelsus, Ozempic, ELIQUIS.
Industry payments across MI — which companies pay providers there.
